We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current EVG market cap is 2.2M. The company's latest EPS is GBP -0.0114 and P/E is -0.70.
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 194k | 0 | 422k | 396k |
| Operating Income | -3.15M | -3.2M | -3.19M | -5.07M | -3.56M |
| Net Income | -2.72M | -2.67M | -2.73M | -4.04M | -3.14M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 4.86M | 12.42M | 9.64M | 6.17M | 3.06M |
| Total Liabilities | 653k | 607k | 411k | 833k | 721k |
| Total Equity | 4.2M | 11.81M | 9.23M | 5.34M | 2.34M |
| Year End 31 March 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -2.58M | -2.93M | -2.58M | -4.13M | -3M |
| Investing | 1,000 | -6.01M | 1.5M | 4.62M | N/A |
| Financing | 4.68M | 10.39M | N/A | N/A | N/A |
| Market Cap | 2.2M |
| Price to Earnings Ratio | -0.70 |
| Price to Sales Ratio | 5.71 |
| Price to Cash Ratio | 1.1 |
| Price to Book Ratio | 0.94 |
| Dividend Yield | - |
| Shares Outstanding | 274.89M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -50.00% |
| 52 Week High | 1.85 |
| 52 Week Low | 0.75 |
| Spread (Intraday) | 0.1 (11.76%) |
| Company Name | Evgen Pharma Plc |
| Address |
alderley park cheshire SK10 4TG |
| Website | https://www.theracryf.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
